Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

FDA approves intramuscular administration of Merck’s MMRV vaccines

Until now, the vaccines have only been administered via subcutaneous injection

- PMLiVE

What are design systems and how can they help you elevate your digital products?

Design Systems aren’t new, but the potential to utilise them to improve the way in which teams produce digital products is still untapped for many in the pharmaceutical and healthcare...

Graphite Digital

- PMLiVE

WHO countries begin negotiations on global pandemic preparedness agreement

The discussions will continue over the next year until a final draft is made in 2024

- PMLiVE

FDA grants priority review for traditional approval of Biogen and Eisai’s Alzheimer’s drug

Leqembi was granted accelerated approval in the US earlier this year

- PMLiVE

Routine gene test could guide use of cancer chemotherapy, new study shows

The test could select advanced bowel cancer patients who would benefit from the treatment

Medscape Oncology: Delivering Impact at ASH

You can read more information on Medscape Oncology at ASH here, or please reach out to Chris Carey or Steve Dunn who can tell you more about how Medscape can help to...

Medscape Education

Medscape Oncology: Delivering Impact at ASH

Medscape Oncology was on-site in New Orleans at ASH 2022. During the 4-day conference, Medscape Oncology hosted educational symposia, interacted with clinicians at our booth, and worked with leading faculty...

Medscape Education

- PMLiVE

Eli Lilly signs agreement worth up to $600m for Confo Therapeutics’ non-opioid pain candidate

Neuropathic pain results from conditions including multiple sclerosis, diabetes, shingles or cancer

- PMLiVE

AstraZeneca announces major expansion of Canadian research footprint

The investment includes the creation of 500 jobs and a new rare disease research hub

- PMLiVE

BioNTech and Weizmann Institute to collaborate at company’s new mRNA centre in Israel

The research facility is expected to start operations by the end of the year

Lianne’s Story – Supporting Deaf People With Their Mental Health

Take a look at how we helped a member of our team to achieve her goal of providing more support to the Deaf community

Mednet

Introduction to Origins

In this short video Mark Corbett, Chief Innovation Officer at Resonant Group, gives a brief introduction to Origins, the patient focused specialist agency.If you'd like to know more, visit the...

Origins – The Patient Focused Specialists

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links